Opioid PrEscRiptions and Usage After Surgery - Prescrizione di oppiacei ed utilizzo nel postchirurgico

Title

Code

OPERAS

Type

Osservazionale

Start Year

2022

Status

Terminato

Principal Investigator

051-6366418

francesco.castagnini@ior.it

Castagnini Francesco, MD

Orthopaedic-Traumatology and Prosthetic surgery and revisions of hip and knee implants

Operational unit that carry out the study

complex unit

Ortopedia-Traumatologia e Chirurgia protesica e dei reimpianti d'anca e di ginocchio

Director

Prof. Traina Francesco

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta allo studio prot. OPERAS

Tuesday 19 July 2022, 16:48

PG0006892_2022_prot. OPERAS.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Opioid PrEscRiptions and Usage After Surgery - Prescrizione di oppiacei ed utilizzo nel postchirurgico

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Opioid PrEscRiptions and Usage After Surgery - Prescrizione di oppiacei ed utilizzo nel postchirurgico

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in